4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide

C35H46N4O4 — CID 71527717

IUPAC4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide
SMILESCN(C)C(=O)c1ccc(COc2ccccc2CN2CCN(C(=O)CNC(=O)CC34CC5CC(CC(C5)C3)C4)CC2)cc1
InChIInChI=1S/C35H46N4O4/c1-37(2)34(42)29-9-7-25(8-10-29)24-43-31-6-4-3-5-30(31)23-38-11-13-39(14-12-38)33(41)22-36-32(40)21-35-18-26-15-27(19-35)17-28(16-26)20-35/h3-10,26-28H,11-24H2,1-2H3,(H,36,40)
InChIKeyRISAAPUSNDFXCS-UHFFFAOYSA-N
MW586.78 g/mol
LogP4.33
Rot. Bonds10

About 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide

4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide (PubChem CID 71527717) has the molecular formula C35H46N4O4 and a molecular weight of 586.78 g/mol. Its IUPAC name is 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide.

Molecular Properties

Compound Name4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide
PubChem CID71527717
Molecular FormulaC35H46N4O4
Molecular Weight586.78 g/mol
Exact Mass586.35
IUPAC Name4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide
SMILESCN(C)C(=O)c1ccc(COc2ccccc2CN2CCN(C(=O)CNC(=O)CC34CC5CC(CC(C5)C3)C4)CC2)cc1
InChIInChI=1S/C35H46N4O4/c1-37(2)34(42)29-9-7-25(8-10-29)24-43-31-6-4-3-5-30(31)23-38-11-13-39(14-12-38)33(41)22-36-32(40)21-35-18-26-15-27(19-35)17-28(16-26)20-35/h3-10,26-28H,11-24H2,1-2H3,(H,36,40)
InChIKeyRISAAPUSNDFXCS-UHFFFAOYSA-N
XLogP4.33
TPSA82.19 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds10
Heavy Atoms43
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500586.78
LogP ≤ 54.33
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide?
The IUPAC name of 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide (CID 71527717) is 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide.
What is the SMILES notation for 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide?
The canonical SMILES for 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide is CN(C)C(=O)c1ccc(COc2ccccc2CN2CCN(C(=O)CNC(=O)CC34CC5CC(CC(C5)C3)C4)CC2)cc1.
What is the InChIKey of 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide?
The InChIKey is RISAAPUSNDFXCS-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H46N4O4/c1-37(2)34(42)29-9-7-25(8-10-29)24-43-31-6-4-3-5-30(31)23-38-11-13-39(14-12-38)33(41)22-36-32(40)21-35-18-26-15-27(19-35)17-28(16-26)20-35/h3-10,26-28H,11-24H2,1-2H3,(H,36,40).
What are the key properties of 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide?
4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide has a molecular weight of 586.78 g/mol, XLogP of 4.33, 10 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[2-[[4-[2-[[2-(1-adamantyl)acetyl]amino]acetyl]piperazin-1-yl]methyl]phenoxy]methyl]-N,N-dimethylbenzamide is sourced from PubChem (CID 71527717), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).